viernes, 29 de junio de 2018

Journal for ImmunoTherapy of Cancer | Immune monitoring technology primers

Journal for ImmunoTherapy of Cancer | Immune monitoring technology primers

JITC logo



Immune monitoring technology primers

Due to advances in cancer immunotherapy, including positive results from clinical trials testing new agents and combinations, emerging new technologies for measuring aspects of immunity, and novel candidate biomarkers from early phase trials, the SITC Immune Biomarkers Task Force has reconvened to review the state of the art, identify current hurdles to further success and to make recommendations to the field.

Reviewed by the members of the SITC Immune Biomarkers Task Force, these brief primers highlight important aspects of both standardized and novel technologies available in clinical trial settings.

No hay comentarios:

Publicar un comentario